2015

1. A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients

   Annals of Oncology, Vol. 26, Núm. 10, pp. 2085-2091

2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

   Journal of the National Cancer Institute, Vol. 107, Núm. 12